Status:
COMPLETED
Two Schedules of Hepatitis B Vaccination in Predialysis Chronic Renal Failure Patients
Lead Sponsor:
Tehran University of Medical Sciences
Conditions:
Renal Failure
Eligibility:
All Genders
25-70 years
Phase:
NA
Brief Summary
Patients with chronic renal disease have to be vaccinated as soon as dialysis is forestalled and this could improve seroconversion rate of hepatitis B vaccination. In this study, the investigators ai...
Detailed Description
In an open, randomized clinical trial, the investigators compared seroconversion rates in 51 predialysis patients with mild and moderate chronic renal failure using either 40 μg 4 doses or 20 μg 3 dos...
Eligibility Criteria
Inclusion
- predialysis patients,
- \> 18 years with mild and moderate chronic renal failure,
- serum creatinine between 1.5-6 mg/dl
Exclusion
- patients with severe renal failure,
- serum creatinine \> 6 mg/dl,
- requiring dialysis or expected to require dialysis within 1 year,
- receiving immunosuppressive treatment,
- known lymphoproliferative disorder.
Key Trial Info
Start Date :
October 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 1 2008
Estimated Enrollment :
51 Patients enrolled
Trial Details
Trial ID
NCT01468051
Start Date
October 1 2008
End Date
October 1 2008
Last Update
November 9 2011
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.